BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23488797)

  • 1. Predicting post renal biopsy complications.
    Sethi I; Brier M; Dwyer A
    Semin Dial; 2013; 26(5):633-5. PubMed ID: 23488797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of clinical complications and risk factors in 1,001 native and transplant kidney biopsies in Sweden.
    Peters B; Andersson Y; Stegmayr B; Mölne J; Jensen G; Dahlberg P; Holm-Gunnarsson I; Ekberg J; Bjurström K; Haux SB; Hadimeri H
    Acta Radiol; 2014 Sep; 55(7):890-6. PubMed ID: 24068748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transjugular renal biopsy: our experience and technical considerations.
    See TC; Thompson BC; Howie AJ; Karamshi M; Papadopoulou AM; Davies N; Tibballs J
    Cardiovasc Intervent Radiol; 2008; 31(5):906-18. PubMed ID: 18266029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound-guided renal biopsy with biopsy gun technique--efficacy and complications.
    Christensen J; Lindequist S; Knudsen DU; Pedersen RS
    Acta Radiol; 1995 May; 36(3):276-9. PubMed ID: 7742122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for bleeding complications in percutaneous renal biopsy.
    Eiro M; Katoh T; Watanabe T
    Clin Exp Nephrol; 2005 Mar; 9(1):40-5. PubMed ID: 15830272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy.
    Manno C; Strippoli GF; Arnesano L; Bonifati C; Campobasso N; Gesualdo L; Schena FP
    Kidney Int; 2004 Oct; 66(4):1570-7. PubMed ID: 15458453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is it necessary to stop antiplatelet agents before a native renal biopsy?
    Mackinnon B; Fraser E; Simpson K; Fox JG; Geddes C
    Nephrol Dial Transplant; 2008 Nov; 23(11):3566-70. PubMed ID: 18503099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk management of renal biopsy: 1387 cases over 30 years in a single centre.
    Stratta P; Canavese C; Marengo M; Mesiano P; Besso L; Quaglia M; Bergamo D; Monga G; Mazzucco G; Ciccone G
    Eur J Clin Invest; 2007 Dec; 37(12):954-63. PubMed ID: 18036029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of post-biopsy ultrasound in predicting complications after percutaneous renal biopsy of native kidneys.
    Waldo B; Korbet SM; Freimanis MG; Lewis EJ
    Nephrol Dial Transplant; 2009 Aug; 24(8):2433-9. PubMed ID: 19246472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transjugular kidney biopsy: enabling safe tissue diagnosis in high risk patients.
    Levi IM; Ben-Dov IZ; Klimov A; Pizov G; Bloom AI
    Isr Med Assoc J; 2011 Jul; 13(7):425-7. PubMed ID: 21838185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous imaging-guided solid organ core needle biopsy: coaxial versus noncoaxial method.
    Hatfield MK; Beres RA; Sane SS; Zaleski GX
    AJR Am J Roentgenol; 2008 Feb; 190(2):413-7. PubMed ID: 18212227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding complications after transcutaneous kidney biopsy in patients with systemic amyloidosis: single-center experience in 101 patients.
    Soares SM; Fervenza FC; Lager DJ; Gertz MA; Cosio FG; Leung N
    Am J Kidney Dis; 2008 Dec; 52(6):1079-83. PubMed ID: 18649980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient pediatric renal transplant biopsy--is it safe?
    Sweeney C; Geary DF; Hebert D; Robinson L; Langlois V
    Pediatr Transplant; 2006 Mar; 10(2):159-61. PubMed ID: 16573600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outpatient percutaneous native renal biopsy: safety profile in a large monocentric cohort.
    Roccatello D; Sciascia S; Rossi D; Naretto C; Bazzan M; Solfietti L; Baldovino S; Menegatti E
    BMJ Open; 2017 Jun; 7(6):e015243. PubMed ID: 28637732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound-guided percutaneous renal biopsy in 295 children and adolescents: role of ultrasound and analysis of complications.
    Franke M; Kramarczyk A; Taylan C; Maintz D; Hoppe B; Koerber F
    PLoS One; 2014; 9(12):e114737. PubMed ID: 25489731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical risk factors associated with bleeding after native kidney biopsy.
    Shidham GB; Siddiqi N; Beres JA; Logan B; Nagaraja HN; Shidham SG; Piering WF
    Nephrology (Carlton); 2005 Jun; 10(3):305-10. PubMed ID: 15958047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous renal biopsy of native kidneys: a single-center experience of 1,055 biopsies.
    Korbet SM; Volpini KC; Whittier WL
    Am J Nephrol; 2014; 39(2):153-62. PubMed ID: 24526094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Percutaneous kidney biopsy, analysis of 26 years: complication rate and risk factors; comment].
    González-Michaca L; Chew-Wong A; Soltero L; Gamba G; Correa-Rotter R
    Rev Invest Clin; 2000; 52(2):125-31. PubMed ID: 10846435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic utility and safety of transjugular kidney biopsy in the obese patient.
    Fine DM; Arepally A; Hofmann LV; Mankowitz SG; Atta MG
    Nephrol Dial Transplant; 2004 Jul; 19(7):1798-802. PubMed ID: 15128881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of complications in percutaneous renal biopsy: what is the optimal period of observation?
    Marwah DS; Korbet SM
    Am J Kidney Dis; 1996 Jul; 28(1):47-52. PubMed ID: 8712221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.